CLINICAL_TRIALS
trial_result
· 2023-04-04
Clinical Trial Update: The Randomized OPTIMAL-ACT Trial [Phase 2]
Summary
A Phase 2 randomized trial (OPTIMAL-ACT) completed with results posted in 2023, evaluating treatment in coronary artery disease and ischemic heart disease conte…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Mayo Clinic | Conditions: Coronary Artery Disease, Ischemic Heart Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-04-04